Mejia-Vilet JM - Search Results

1

Molecular profiling of kidney compartments from serial biopsies differentiate treatment responders from non-responders in lupus nephritis.

Parikh SV, Malvar A, Song H, Shapiro J, Mejia-Vilet JM, Ayoub I, Almaani S, Madhavan S, Alberton V, Besso C, Lococo B, Satoskar A, Zhang J, Yu L, Fadda P, Eadon M, Birmingham D, Ganesan LP, Jarjour W, Rovin BH. Parikh SV, et al. Kidney Int. 2022 Oct;102(4):845-865. doi: 10.1016/j.kint.2022.05.033. Epub 2022 Jul 2. Kidney Int. 2022. PMID: 35788359 Free PMC article.

2

High Mortality of COVID-19 in Young Mexican Patients With Rheumatic Diseases: Comparative Analysis Versus the General Population.

Martínez-Martínez MU, Colunga-Pedraza IJ, Irazoque-Palazuelos F, Reyes-Cordero G, Rodriguez-Reyna TS, Veloz-Aranda JA, Skinner-Taylor CM, Juárez-Mora IM, Silveira LH, Zazueta-Montiel BE, Castillo-Ortiz AA, Martínez A, Zamora-Tehozol E, Maya-Piña LV, Perez-Barbosa L, Galarza-Delgado DA, Hernandez MDC, Marquez-Miranda O, Andrade-Ortega L, Fuentes-Hernandez MN, Morales DV, Aguiar MC, Oostdam DAH, Loredo-Alanis SA, Martín-Nares E, Durán-Barragán S, Jiménez-Jiménez X, Vázquez-Del Mercado M, Moctezuma-Rios JF, Rull-Gabayet M, Barragán-Garfías JA, Tena CFP, Xibille-Friedmann DX, Alpizar-Rodriguez D; Mexican Study Group of COVID-19 in Rheumatic Diseases. Martínez-Martínez MU, et al. J Clin Rheumatol. 2024 Aug 1;30(5):e143-e148. doi: 10.1097/RHU.0000000000002086. Epub 2024 May 16. J Clin Rheumatol. 2024. PMID: 38753050 No abstract available.

3

Renal flare prediction and prognosis in lupus nephritis Hispanic patients.

Mejía-Vilet JM, Córdova-Sánchez BM, Arreola-Guerra JM, Morales-Buenrostro LE, Uribe-Uribe NO, Correa-Rotter R. Mejía-Vilet JM, et al. Lupus. 2016 Mar;25(3):315-24. doi: 10.1177/0961203315606985. Epub 2015 Sep 24. Lupus. 2016. PMID: 26405028

4

Renal Thrombotic Microangiopathy in Proliferative Lupus Nephritis: Risk Factors and Clinical Outcomes: A Case-Control Study.

Barrera-Vargas A, Rosado-Canto R, Merayo-Chalico J, Arreola-Guerra JM, Mejía-Vilet JM, Correa-Rotter R, Gómez-Martín D, Alcocer-Varela J. Barrera-Vargas A, et al. J Clin Rheumatol. 2016 Aug;22(5):235-40. doi: 10.1097/RHU.0000000000000425. J Clin Rheumatol. 2016. PMID: 27464767

5

Prognostic significance of renal vascular pathology in lupus nephritis.

Mejía-Vilet JM, Córdova-Sánchez BM, Uribe-Uribe NO, Correa-Rotter R, Morales-Buenrostro LE. Mejía-Vilet JM, et al. Lupus. 2017 Sep;26(10):1042-1050. doi: 10.1177/0961203317692419. Epub 2017 Feb 8. Lupus. 2017. PMID: 28178879

6

Immune gene expression in kidney biopsies of lupus nephritis patients at diagnosis and at renal flare.

Mejia-Vilet JM, Parikh SV, Song H, Fadda P, Shapiro JP, Ayoub I, Yu L, Zhang J, Uribe-Uribe N, Rovin BH. Mejia-Vilet JM, et al. Nephrol Dial Transplant. 2019 Jul 1;34(7):1197-1206. doi: 10.1093/ndt/gfy125. Nephrol Dial Transplant. 2019. PMID: 29800348 Free PMC article.

7

Establishing Surrogate Kidney End Points for Lupus Nephritis Clinical Trials: Development and Validation of a Novel Approach to Predict Future Kidney Outcomes.

Mackay M, Dall'Era M, Fishbein J, Kalunian K, Lesser M, Sanchez-Guerrero J, Levy DM, Silverman E, Petri M, Arriens C, Lewis EJ, Korbet SM, Conti F, Tesar V, Hruskova Z, Borba EF, Bonfa E, Chan TM, Rathi M, Gupta KL, Jha V, Hasni S, West MR, Solomons N, Houssiau FA, Romero-Diaz J, Mejia-Vilet J, Rovin BH. Mackay M, et al. Arthritis Rheumatol. 2019 Mar;71(3):411-419. doi: 10.1002/art.40724. Epub 2019 Feb 1. Arthritis Rheumatol. 2019. PMID: 30225865

8

Calcineurin Inhibitors With Reduced-Dose Steroids as First-Line Therapy for Focal Segmental Glomerulosclerosis.

Chávez-Mendoza CA, Niño-Cruz JA, Correa-Rotter R, Uribe-Uribe NO, Mejía-Vilet JM. Chávez-Mendoza CA, et al. Kidney Int Rep. 2018 Aug 31;4(1):40-47. doi: 10.1016/j.ekir.2018.08.010. eCollection 2019 Jan. Kidney Int Rep. 2018. PMID: 30596167 Free PMC article.

9

Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Floege J, Barbour SJ, Cattran DC, Hogan JJ, Nachman PH, Tang SCW, Wetzels JFM, Cheung M, Wheeler DC, Winkelmayer WC, Rovin BH; Conference Participants. Floege J, et al. Kidney Int. 2019 Feb;95(2):268-280. doi: 10.1016/j.kint.2018.10.018. Kidney Int. 2019. PMID: 30665568 Free article.

10

Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Rovin BH, Caster DJ, Cattran DC, Gibson KL, Hogan JJ, Moeller MJ, Roccatello D, Cheung M, Wheeler DC, Winkelmayer WC, Floege J; Conference Participants. Rovin BH, et al. Kidney Int. 2019 Feb;95(2):281-295. doi: 10.1016/j.kint.2018.11.008. Kidney Int. 2019. PMID: 30665569 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters